Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $90.9000 (0.56%) ($89.5600 - $91.1100) on Mon. Dec. 23, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.59% (three month average) | RSI | 56 | Latest Price | $90.9000(0.56%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(43%) IBB(40%) VFMO(40%) VT(40%) VYM(40%) | Factors Impacting UTHR price | UTHR will decline at least -0.795% in a week (0% probabilities). VIXM(-30%) VXX(-20%) TLT(-13%) UUP(-1%) TIP(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.795% (StdDev 1.59%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
1 - 5 Day Possible Target | $87.72(-3.5%) | Resistance Level | $91.44 | 5 Day Moving Average | $89.98(1.02%) | 10 Day Moving Average | $90.91(-0.01%) | 20 Day Moving Average | $91.44(-0.59%) | To recent high | -4.7% | To recent low | 16.1% | Market Cap | $4.032b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |